This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Measurement of Renal Function With Iohexol in Subjects Ingesting Carnitine

This study has been withdrawn prior to enrollment.
Information provided by:
Montefiore Medical Center Identifier:
First received: July 11, 2011
Last updated: NA
Last verified: July 2011
History: No changes posted
The investigators will measure renal function in subjects ingesting carnitine to determine if the product alters renal function.

Condition Intervention
Carnitine Ingestion Dietary Supplement: Carnitine

Study Type: Interventional
Study Design: Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Measurement of Glomerular Filtration Rate (GFR) Using Iohexol in Healthy Subjects Taking Creatinine Supplements

Resource links provided by NLM:

Further study details as provided by Montefiore Medical Center:

Primary Outcome Measures:
  • Iohexol clearance [ Time Frame: 1 month ]
    Iohexol clearance will be measured

Estimated Enrollment: 5
Study Start Date: May 2010
Estimated Study Completion Date: June 2010
Estimated Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Dietary Supplement: Carnitine
    Carnitine Ingestion

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • carnitine ingestion

Exclusion Criteria:

  • renal disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01392313

United States, New York
Montefiore Medical Center
Bronx, New York, United States, 10467
Sponsors and Collaborators
Montefiore Medical Center
  More Information

Responsible Party: Joel Neugarten MD, Montefiore Medical Center Identifier: NCT01392313     History of Changes
Other Study ID Numbers: 10-03-068
Study First Received: July 11, 2011
Last Updated: July 11, 2011

Keywords provided by Montefiore Medical Center:
carnitine, kidney processed this record on August 18, 2017